Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Surg Res. 2021 Jan 21;261:334–342. doi: 10.1016/j.jss.2020.12.045

Figure 3:

Figure 3:

HJC0416 inhibited the STAT3 pathway

(A) HJC0416 decreased total and nuclear levels of phosphorylated STAT3 in LX-2 cells. (B) HJC0416 decreased total and nuclear levels of phosphorylated STAT3 in HSC-T6 cells. (C) HJC0416 decreases STAT3 signal transduction pathway activation. (D) STAT3 downstream targets c-myc and cyclin D1 expression are decreased after HJC0416 treatment. The results are representative of at least three different experiments.